title: Evaluation and comparison of human absorbed dose of (90)Y-DOTA-Cetuximab in various age groups based on distribution data in rats.
abstract: The organ radiation-absorbed doses have been evaluated for humans in six age groups and both genders based on animal data. After intravenous administration of (90)Y-DOTA-Cetuximab to five groups of rats, they were sacrificed at exact time intervals (2, 24, 48, 72, and 96 h) and the percentage of injected dose per gram of each organ was calculated by direct counting from rat data. By using the formulation that Medical Internal Radiation Dose suggests, radiation-absorbed doses for all organs were calculated and extrapolated from rat to human. The total body absorbed dose for all groups was >22 mGy due to pure β-emission of the applied radiopharmaceutical. The effective dose resulting from an intravenously injected activity of 100 MBq is 56.7 mSv for a 60-kg female adult and 60.3 mSv for a 73-kg male adult. The results demonstrated the usefulness of this method for estimation of β-absorbed dose in humans.
authors.affiliation: Department of Medical Radiation Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
authors.forename: Ariandokht
authors.initials: A
authors.lastname: Vakili
authors.forename: Amir Reza
authors.initials: AR
authors.lastname: Jalilian
authors.forename: Alireza Khorrami
authors.initials: AK
authors.lastname: Moghadam
authors.forename: Maryam
authors.initials: M
authors.lastname: Ghazi-Zahedi
authors.forename: Bahram
authors.initials: B
authors.lastname: Salimi
keywords: Absorbed dose; Yttrium-90; beta-particles; internal dosimetry